Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties

Kola I., 2004, Nat. Rev. Drug Discovery, 3, 711, 10.1038/nrd1470

Leeson P. D., 2007, Nat. Rev. Drug Discovery, 6, 881, 10.1038/nrd2445

Abad-Zapatero C., 2007, Expert Opin. Drug Discovery, 2, 469, 10.1517/17460441.2.4.469

Keserue G. M., 2009, Nat. Rev. Drug Discovery, 8, 203, 10.1038/nrd2796

Kalgutkar A. S., 2008, Biotechnol.: Pharm. Aspects, 9, 27

Kalgutkar A. S., 2005, Curr. Drug Metab., 6, 161, 10.2174/1389200054021799

Kalgutkar A. S., 2005, Expert Opin. Drug Metab. Toxicol., 1, 91, 10.1517/17425255.1.1.91

10.1021/cn100007x

Ertl P., 2000, J. Med. Chem., 43, 3714, 10.1021/jm000942e

Feng B., 2008, Drug Metab. Dispos., 36, 268, 10.1124/dmd.107.017434

Hosea N. A., 2009, J. Clin. Pharmacol., 49, 513, 10.1177/0091270009333209

Gao H., 2008, Drug Metab. Dispos., 36, 2130, 10.1124/dmd.107.020131

Hughes J. D., 2008, Bioorg. Med. Chem. Lett., 18, 4872, 10.1016/j.bmcl.2008.07.071

Lipinski C. A., 2004, Drug Discovery Today: Technol., 1, 337, 10.1016/j.ddtec.2004.11.007

Waterhouse Rikki N., 2003, Mol. Imaging Biol., 5, 376, 10.1016/j.mibio.2003.09.014

E. C. Harrington J., 1965, Ind. Qual. Control, 21, 494

Le Bailly de Tilleghem C., 2005, J. Chem. Inf. Model., 45, 758, 10.1021/ci049787t

Mandal A., 2007, J. Chem. Inf. Model., 47, 981, 10.1021/ci600556v

Gehlhaar D. K., 1995, Chem. Biol., 2, 317, 10.1016/1074-5521(95)90050-0

Deacon M., 2007, J. Pharmacol. Toxicol. Methods, 55, 238, 10.1016/j.vascn.2006.09.003

Lowe C. W., 1967, Trans. Inst. Chem. Eng., 45, T3

JMP. ( (1989−2007) SAS JMP 7,SAS Institute, Inc.,Cary, NC.

Spotfire. (1996−2007) Spotfire Decision Site 9,TIBCO Softrware Inc.,Somerville, MA.

Walum E., 2005, Toxicol. Appl. Pharmacol., 207, S393, 10.1016/j.taap.2005.01.056

Fermini B., 2003, Nat. Rev. Drug Discovery, 2, 439, 10.1038/nrd1108